Evolent director granted 41,096 restricted stock units

GRUA PETER J reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

GRUA PETER J reported acquisition or exercise transactions in this Form 4 filing.

Evolent Health, Inc. director Peter J. Grua reported a compensation-related equity grant rather than an open-market trade. He received 41,096 shares of Class A Common Stock in the form of restricted stock units at $0.00 per share under the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan. These securities vest on the earlier of June 4, 2027 and the date of the company’s 2027 annual meeting, subject to his continued service. Following the grant, he directly holds 63,075 shares, and a trust for his sole benefit holds an additional 60,668 shares over which he has sole voting and dispositive power.

Insider Trade Summary

Grant/Award: 41,096 shares

Grant/Award 2 txns

Insider GRUA PETER J

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Class A Common Stock	41,096	$0.00	$0.00
holding	Class A Common Stock	--	--	--

Holdings After Transaction: Class A Common Stock — 63,075 shares (Direct); Class A Common Stock — 60,668 shares (Indirect, By the Peter J. Grua 2004 Revocable Trust)

Footnotes (3)

1. F1. Represents restricted stock units granted to Mr. Grua pursuant to the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan.
2. F2. Securities vest on the earlier of June 4, 2027, and the date of the Company's 2027 annual meeting, subject to the reporting person's continued service on the vesting date.
3. F3. These shares are held in a trust for the sole benefit of the reporting person. The reporting person is the sole trustee of the trust and has sole voting and dispositive power over the shares.

Key Figures

RSU grant size: 41,096 shares Grant price: $0.00 per share Vesting date: June 4, 2027 +2 more

5 metrics

RSU grant size 41,096 shares Restricted stock units granted to director Peter J. Grua

Grant price $0.00 per share Price for Class A Common Stock RSUs

Vesting date June 4, 2027 Earlier of June 4, 2027 and 2027 annual meeting

Direct holdings after grant 63,075 shares Class A Common Stock held directly by Peter J. Grua

Indirect trust holdings 60,668 shares Held by the Peter J. Grua 2004 Revocable Trust

Key Terms

restricted stock units, Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan, vesting, dispositive power

4 terms

restricted stock units financial

"Represents restricted stock units granted to Mr. Grua pursuant to the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan financial

"Represents restricted stock units granted to Mr. Grua pursuant to the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan."

vesting financial

"Securities vest on the earlier of June 4, 2027, and the date of the Company's 2027 annual meeting, subject to the reporting person's continued service on the vesting date."

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

dispositive power financial

"The reporting person is the sole trustee of the trust and has sole voting and dispositive power over the shares."

Dispositive power is the authority to decide the final outcome of an asset, legal claim, contract, or corporate action — in effect the power to dispose of or resolve something. For investors it matters because whoever holds that authority can determine who gets paid, who controls an asset or vote, and how risks and returns are allocated; think of it like holding the key that lets you lock in the winner or loser in a deal.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Evolent Health (EVH) director Peter J. Grua report?

Peter J. Grua reported receiving a grant of restricted stock units covering 41,096 shares of Evolent Health Class A Common Stock. The grant is compensation-related, carries a $0.00 per-share price, and is disclosed as a non-derivative acquisition on the Form 4 filing.

How many Evolent Health (EVH) shares were granted to Peter J. Grua and at what price?

He was granted 41,096 shares of Class A Common Stock through restricted stock units at $0.00 per share. This reflects an equity award under the Amended and Restated 2015 Omnibus Incentive Compensation Plan, rather than an open-market purchase of EVH shares.

When do Peter J. Grua’s new Evolent Health (EVH) restricted stock units vest?

The restricted stock units vest on the earlier of June 4, 2027 and the date of Evolent Health’s 2027 annual meeting. Vesting is conditioned on Mr. Grua’s continued service with the company through the applicable vesting date as disclosed in the filing.

What are Peter J. Grua’s Evolent Health (EVH) share holdings after this grant?

After the grant, he directly holds 63,075 shares of Evolent Health Class A Common Stock. In addition, a trust for his sole benefit holds 60,668 shares, and he has sole voting and dispositive power over those trust-held shares according to the footnote.

Are Peter J. Grua’s new Evolent Health (EVH) shares held directly or through a trust?

The newly granted 41,096 restricted stock units increase his direct holdings to 63,075 shares. Separately, 60,668 shares are held indirectly through the Peter J. Grua 2004 Revocable Trust, where he serves as sole trustee with full voting and dispositive power.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/08/2026 - 04:27 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

GRUA PETER J

(Last) (First) (Middle)

C/O EVOLENT HEALTH, INC.

1812 N. MOORE ST., STE. 1705

(Street)

ARLINGTON VIRGINIA 22209

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Evolent Health, Inc. [ EVH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/04/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock(1)	06/04/2026		A		41,096(2)	A	$0	63,075	D
Class A Common Stock								60,668	I	By the Peter J. Grua 2004 Revocable Trust(3)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents restricted stock units granted to Mr. Grua pursuant to the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan.

2. Securities vest on the earlier of June 4, 2027, and the date of the Company's 2027 annual meeting, subject to the reporting person's continued service on the vesting date.

3. These shares are held in a trust for the sole benefit of the reporting person. The reporting person is the sole trustee of the trust and has sole voting and dispositive power over the shares.

Remarks:

	/s/ Jonathan Weinberg, Attorney-in-fact	06/08/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)